东曜药业-B将向药明生物交付十批单克隆抗体中间体

美股速递
Jun 17

东曜药业-B已与药明生物达成协议,将分十批次向其供应单克隆抗体药物生产所需的关键中间体。此次交付标志着双方在生物制药领域的合作进一步深化。单克隆抗体中间体是生物药生产链条中的重要环节,此次批量供应将助力药明生物加速相关药物的开发与生产进程。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10